ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,497,361, issued on Dec. 16, was assigned to CAAMTECH INC. (Issaquah, Wash.).
"Crystalline tryptamine compounds" was invented by Andrew R. Chadeayne (Issaquah, Wash.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to 2-(5-hydroxy-1H-indol-3-yl)ethan-1-aminium hydrate chloride (5-HT hydrochloride hydrate) and its crystalline form 1, and to pharmaceutical compositions containing 5-HT hydrochloride hydrate or its crystalline form 1 and to methods of treatment using them. The disclosure further relates to crystalline form 1 of (2E)-but-2-enedioic acid bis({2-[4-(acetyloxy)-1H-indol-3-yl]ethyl}(ethyl)propylazanium) (2E)-but-2-enedioate (...